News

Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), and Servier, an international…
Read More...

MIMETAS announces the first product release of her Assay Ready product line: OrganoPlate Caco-2. The product consists of 38 intestinal tubules that are grown under flow conditions…
Read More...

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing is pleased to announce the signing of a…
Read More...

Inovio Pharmaceuticals, Inc. announced an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infection the World Health Organization (WHO)…
Read More...

Heat Biologics, Inc. announced that the Company has formally launched a program within its wholly-owned subsidiary, Zolovax, Inc., to develop a vaccine using its immune activating gp96…
Read More...

ACADIA Pharmaceuticals Inc. and Neuren Pharmaceuticals Limited announced that the U.S. Food and Drug Administration (FDA) granted Rare Pediatric Disease (RPD) designation to trofinetide…
Read More...

MilliporeSigma launched its LANEXO Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and…
Read More...

Eli Lilly and Company issued the following statement today regarding the novel coronavirus: Among the concerns raised due to the impact of the novel coronavirus is whether patients…
Read More...

Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced that study enrolment of its international ARGOS-SC01 clinical study was completed with the…
Read More...

CYTOO announced that it has entered into a research collaboration aimed at selecting a gene therapy candidate for a rare muscle disorder with Asklepios BioPharmaceutical, Inc. (AskBio),…
Read More...

AstraZeneca announced that it has completed the previously communicated agreement with Atnahs Pharma (Atnahs) to divest its global commercial rights to Inderal (propranolol), Tenormin…
Read More...

Mateon Therapeutics, Inc. dedicated to development OT-101, a TGF-Beta antisense drug candidate, provided an update on its rapid antiviral response program initially targeting the…
Read More...

Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the…
Read More...

Gilead Sciences, Inc. and Forty Seven, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Forty Seven for $95.50 per share…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A.,…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Esbriet (pirfenidone) for adults with…
Read More...

zPREDICTA is pleased to announce that it has entered into a strategic collaboration with LabCorp, a leading global life sciences company. The agreement will support the adoption of…
Read More...

Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from lead candidate selection to proof of concept,…
Read More...

Biogen Inc. and Sangamo Therapeutics, Inc. announced that they have executed a global licensing collaboration agreement to develop and commercialize ST-501 for tauopathies including…
Read More...

Takeda Pharmaceutical Company Limited announced that it has acquired PvP Biologics, Inc. following the conclusion of a Phase 1 proof-of-mechanism study of investigational medicine…
Read More...